Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation

被引:497
作者
Livnah, O
Stura, EA
Middleton, SA
Johnson, DL
Jolliffe, LK
Wilson, LA
机构
[1] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[3] RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA
关键词
D O I
10.1126/science.283.5404.987
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Erythropoietin receptor (EPOR) is thought to be activated by Ligand-induced homodimerization. However, structures of agonist and antagonist peptide complexes of EPOR, as well as an EPO-EPOR complex, have shown that the actual dimer configuration is critical for the biological response and signal efficiency. The crystal structure of the extracellular domain of EPOR in its unliganded form at 2.4 angstrom resolution has revealed a dimer in which the individual membrane-spanning and intracellular domains would be too far apart to permit phosphorylation by JAK2. This unliganded EPOR dimer is formed from self-association of the same key binding site residues that interact with EPO-mimetic peptide and EPO Ligands. This model for a preformed dimer on the cell surface provides insights into the organization, activation, and plasticity of recognition of hematopoietic cell surface receptors.
引用
收藏
页码:987 / 990
页数:4
相关论文
共 54 条
  • [1] Structural plasticity in a remodeled protein-protein interface
    Atwell, S
    Ultsch, M
    DeVos, AM
    Wells, JA
    [J]. SCIENCE, 1997, 278 (5340) : 1125 - 1128
  • [2] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [3] CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
    BANNER, DW
    DARCY, A
    JANES, W
    GENTZ, R
    SCHOENFELD, HJ
    BROGER, C
    LOETSCHER, H
    LESSLAUER, W
    [J]. CELL, 1993, 73 (03) : 431 - 445
  • [4] A DOMINANT-NEGATIVE ERYTHROPOIETIN (EPO) RECEPTOR INHIBITS EPO-DEPENDENT GROWTH AND BLOCKS F-GP55-DEPENDENT TRANSFORMATION
    BARBER, DL
    DEMARTINO, JC
    SHOWERS, MO
    DANDREA, AD
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (04) : 2257 - 2265
  • [5] Mutagenesis studies of the human erythropoietin receptor - Establishment of structure-function relationships
    Barbone, FP
    Middleton, SA
    Johnson, DL
    McMahon, FJ
    Tullai, J
    Gruninger, RH
    Schilling, AE
    Jolliffe, LK
    Mulcahy, LS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) : 4985 - 4992
  • [7] Brosig B, 1998, PROTEIN SCI, V7, P1052
  • [8] ERYTHROPOIETIN RECEPTOR CHARACTERISTICS ON PRIMARY HUMAN ERYTHROID-CELLS
    BROUDY, VC
    LIN, N
    BRICE, M
    NAKAMOTO, B
    PAPAYANNOPOULOU, T
    [J]. BLOOD, 1991, 77 (12) : 2583 - 2590
  • [9] Brunger A. T., 1992, X PLOR VERSION 3 1 S
  • [10] SOLUTION OF A FAB-(26-10)/DIGOXIN COMPLEX BY GENERALIZED MOLECULAR REPLACEMENT
    BRUNGER, AT
    [J]. ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 : 195 - 204